<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Heart transplantation is the ultimate treatment for end-stage <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">Cardiac sarcoidosis</z:e> has rarely been reported in heart transplantation worldwide </plain></SENT>
<SENT sid="2" pm="."><plain>Their long-term prognosis after heart transplantation is unknown </plain></SENT>
<SENT sid="3" pm="."><plain>Herein we have presented clinical and pathological observations among heart transplantation patients with isolated <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: From 1987 to 2011, we performed 411 heart transplantations including five patients retrospectively reviewed due to the presence of <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> and giant-cell <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in the recipient heart </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among the heart transplantations from 2003 to 2011, the four male and one female patients were ages 31 to 40 years </plain></SENT>
<SENT sid="6" pm="."><plain>None of them had extra-<z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> five subjects presented with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> with patent coronary arteries </plain></SENT>
<SENT sid="8" pm="."><plain>The commonest clinical presentations were <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo>, <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo>, electrocardiographic findings of ST elevations, and poor left ventricular ejection fractions (17%-23%) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients survived without allograft <z:hpo ids='HP_0001635'>heart failure</z:hpo> to date with the longest survivor at 8 years postoperatively </plain></SENT>
<SENT sid="10" pm="."><plain>No recurrence of <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> has been observed clinically or among the post-heart transplantation endomyocardial biopsies </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Heart transplantation is a useful treatment for isolated <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> patients suffering end-stage <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Often the diagnosis is difficult to establish before heart transplantation despite endomyocardial biopsy </plain></SENT>
<SENT sid="13" pm="."><plain>No recurrence of <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> was observed among the allografted hearts </plain></SENT>
</text></document>